What is HRD (Homologous Recombination Deficiency) and how does it impact ovarian cancer? Mostrare di più
In this webinar, the Ovacome team are joined by Dr Rowan Miller, Consultant Medical Oncologist specialising in gynae-oncology and early phase clinical trials at University College London and St Bartholomew's Hospitals. Dr Miller provides an overview of what exactly HRD is, and how it can impact ovarian cancers and their treatment.
For ovarian cancer information and support, visit https://www.ovacome.org.uk/
If you have any questions about ovarian cancer, or want to talk things through, call 0800 008 7054 or email [email protected] .
Updates in ovarian cancer research, with Dr Rowan Miller Mostrare di più
As part of our Staying Connected programme of online events, Ovacome were joined Dr Rowan Miller, Consultant Medical Oncologist specialising in gynae-oncology and early phase clinical trials at University College London and St Bartholomew's Hospitals. Dr Miller provided a general presentation on the most recent developments in ovarian cancer research and treatment, looking at current focuses and potential future research.
To view all upcoming Ovacome online webinars, workshops and support groups, visit https://www.ovacome.org.uk/Pages/Events/Category/come-to-our-events